Metal-Organic Framework for Hypoxia/ROS/pH Triple-Responsive Cargo Release.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapy

Background:

• Photodynamic therapy (PDT) faces challenges with short reactive oxygen species (ROS) lifetimes and limited diffusion distances.
• Developing effective drug delivery systems is crucial for enhancing PDT efficacy.

Purpose of the Study:

• To design a hypoxia/ROS/pH triple-responsive metal-organic framework (MOF) for triggered photosensitizer release.
• To improve antitumor efficacy of PDT by addressing limitations of ROS diffusion and lifetime.

Main Methods:

• Synthesized a zinc-based MOF encapsulated with Chlorin e6 (Ce6) photosensitizer, utilizing an azo-containing imidazole ligand.
• Investigated the MOF's responsiveness to hypoxia (via azo reduction), acidic pH (via imidazole ionization), and ROS (via imidazole oxidation).
• Evaluated the synergistic effects of these triggers on photosensitizer release and PDT efficacy.

Main Results:

• The azo group's reduction in hypoxic conditions depleted antioxidants (GSH, Trx), facilitating rapid cargo release.
• Imidazole ionization in acidic organelles promoted lysosomal escape and Ce6 release.
• ROS-induced imidazole oxidation further enhanced cargo release, demonstrating synergistic effects.
• The triple-responsive system improved photosensitizer release rates and enhanced PDT therapy.

Conclusions:

• Triple-responsive nanocarriers offer a promising strategy for triggered photosensitizer release in PDT.
• This approach effectively overcomes limitations associated with ROS in antitumor PDT.
• The developed MOF system demonstrates potential for improved cancer treatment outcomes.